Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Should You Buy Imperial Tobacco Group PLC (LIMT)? – British American Tobacco PLC (ADR) (BTI)

LONDON — I believe Imperial Tobacco Group PLC (LON:IMT) is an excellent pick for the savvy income investor, as the company carries an enviable track record of hiking dividends.

Imperial Tobacco has experienced weakness in crucial markets in recent times, but I reckon the strength of its key brands and recently announced cost-cutting measures should help safeguard earnings.

Strategic cost-cutting to defend the bottom line
Imperial Tobacco Group PLC (LON:IMT) — whose flagship brands include Gauloises Blondes, Davidoff,West, and John Player Special — announced earlier this month plans to become much leaner and efficient.

The company aims to generate 300 million pounds of cost savings per year until Sept. 2018, starting in October. Also, the new strategy will see it “shutter” 150 local brands that make up around 60% of volumes, yet are dropping at an alarming rate of 6% per year.

January’s interims showed net revenues crawl just 2% higher in the third quarter, while stick volumes dropped 1% as conditions in key regions such as Europe and Russia continued to deteriorate.

British American Tobacco PLCBut Imperial Tobacco Group PLC (LON:IMT)’s ambitious plans to boost efficiency, coupled with ongoing strength among its bellwether products — net revenue and volumes across its key brands rose 12% and 10%, respectively, in the first quarter — should continue to deliver dependable earnings growth over the medium term.

Earnings growth to maintain steady momentum
City analysts forecast earnings per share could creep 5% higher to 212 pence in the year ending Sept. 2013, before rising a further 8% to 228 pence in the following 12-month period.

Imperial Tobacco Group PLC (LON:IMT) currently trades on a P/E rating of 11.4 for the current year, which is projected to drop to 10.6 in 2014. These ratings compare favorably with a forward multiple of 13.5 for the broader tobacco sector.

Gear up for solid dividend growth
Imperial Tobacco operates a very solid, progressive dividend policy that outstrips that of its rivals. A dividend yield of 4.8% is forecast for 2013, which is expected to leap to 5.3% next year. These yields compare with rival British American Tobacco PLC (ADR) (NYSEAMEX:BTI)’s 4.2% and 4.6% yields forecast for the next two years.

Imperial Tobacco upped its dividend per share 11% last year to 105.6 pence, and further chunky payout increases are expected this year and next, according to broker estimates, to 115.7 pence and 127.8 pence, respectively.

Shareholder payouts do not enjoy supreme coverage, though, with predicted dividends covered 1.8 times this year and next. But Imperial Tobacco’s position in the ultra-defensive tobacco industry should dispel fears over future dividend cuts, in my opinion.

Smoke out other sterling stocks
If you already hold shares in Imperial Tobacco, I’d now urge you to check out this special report, which highlights other FTSE winners identified by ace fund manager Neil Woodford.

The article Should You Buy Imperial Tobacco Group? originally appeared on Fool.com and is written by Royston Wild.

Royston Wild does not own shares in Imperial Tobacco Group or British American Tobacco. The Motley Fool has no position in any of the stocks mentioned.

Copyright © 1995 – 2013 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...
X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!